IM Cannabis Corp. Regains Nasdaq Equity Compliance
Ticker: IMCC · Form: 6-K · Filed: Sep 5, 2025 · CIK: 1792030
| Field | Detail |
|---|---|
| Company | Im Cannabis CORP. (IMCC) |
| Form Type | 6-K |
| Filed Date | Sep 5, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Sentiment: bullish
Topics: compliance, listing, nasdaq
TL;DR
IM Cannabis Corp. back in Nasdaq's good graces, equity compliance restored.
AI Summary
On September 5, 2025, IM Cannabis Corp. announced it has regained compliance with the Nasdaq Stockholders' Equity Listing Requirement. This is a significant development for the company as it allows them to continue trading on the Nasdaq Stock Market.
Why It Matters
Regaining compliance with Nasdaq's equity requirement is crucial for IM Cannabis Corp. as it ensures continued listing on the exchange, providing liquidity and investor confidence.
Risk Assessment
Risk Level: medium — While regaining compliance is positive, the company's financial health and ability to maintain this status going forward present ongoing risks.
Key Players & Entities
- IM Cannabis Corp. (company) — Registrant
- Nasdaq (company) — Stock Exchange
- September 5, 2025 (date) — Date of press release
FAQ
What specific Nasdaq Stockholders' Equity Listing Requirement did IM Cannabis Corp. regain compliance with?
The filing states that IM Cannabis Corp. regained compliance with the Nasdaq Stockholders' Equity Listing Requirement, but does not specify the exact numerical threshold or rule number.
When was the press release announcing this compliance issued?
The press release announcing the regained compliance was issued on September 5, 2025.
What is the Commission File Number for IM Cannabis Corp.?
The Commission File Number for IM Cannabis Corp. is 001-40065.
What form is this filing?
This filing is a Form 6-K, Report of Foreign Private Issuer.
What is the principal executive office address of IM Cannabis Corp.?
The principal executive office address of IM Cannabis Corp. is 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4.
Filing Stats: 267 words · 1 min read · ~1 pages · Grade level 11 · Accepted 2025-09-05 07:27:51
Filing Documents
- zk2533761.htm (6-K) — 11KB
- exhibit_99-1.htm (EX-99.1) — 9KB
- 0001178913-25-003251.txt ( ) — 21KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F CONTENTS On September 5, 2025, IM Cannabis Corp. (the "Company") issued a press release titled: "IM Cannabis Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement". A copy of this press release is furnished herewith as Exhibit 99.1. This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company's Registration Statements on Form F-3 (File No. 333-289571 and 333-288346 ) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished. EXHIBIT INDEX Exhibit No. 99.1 Press Release dated September 5, 2025, titled "IM Cannabis Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement". SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IM CANNABIS CORP. (Registrant) Date: September 5, 2025 By: /s/Oren Shuster Name: Oren Shuster Title: Chief Executive Officer and Director